MRS-3777 hemioxalate

CAS No. 1186195-57-2

MRS-3777 hemioxalate( —— )

Catalog No. M33032 CAS No. 1186195-57-2

MRS-3777 hemioxalate, a selective adenosine A3 receptor antagonist, reverses the anti-injury perception effects of its corresponding agonist and serves as a valuable tool for studying inflammatory pain.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 105 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MRS-3777 hemioxalate
  • Note
    Research use only, not for human use.
  • Brief Description
    MRS-3777 hemioxalate, a selective adenosine A3 receptor antagonist, reverses the anti-injury perception effects of its corresponding agonist and serves as a valuable tool for studying inflammatory pain.
  • Description
    MRS-3777 hemioxalate is a selective adenosine A3 receptor antagonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Adenosine Receptor
  • Recptor
    Adenosine Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1186195-57-2
  • Formula Weight
    354.39
  • Molecular Formula
    C17H19N5O.1/2C2H2O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (250.38 mM; Ultrasonic; (HCL,pH≈3); )H2O : < 0.1 mg/mL (insoluble)
  • SMILES
    O=C(O)C(=O)O.N1=CNC2=C1N=C(N=C2NC3CCCCC3)OC=4C=CC=CC4 0.5 Oxalic Acid
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Nascimento FP, et al. Inosine reduces pain-related behavior in mice: involvement of adenosine A1 and A2A receptorsubtypes and protein kinase C pathways. J Pharmacol Exp Ther. 2010 Aug;334(2):590-8.?
molnova catalog
related products
  • SCH 412348

    SCH 412348 is a potent and highly selective A2A receptor competitive antagonist with Ki of 0.6 nM.

  • GS-9667

    GS-9667, a selective and partial agonist of the A(1) adenosine receptor (AR), represents an effective therapy for Type 2 diabetes (T2DM) and dyslipidemia via lowering of free fatty acids (FFA).

  • ISAM-140

    ISAM-140 is a potent and highly selective antagonist of A2B adenosine receptor.